← All stocks

Surrozen, Inc./DE

SRZN Net buying
CIK 0001824893 #3678 in the set updated 17 Sep 2026
Bought (120 mo)
$34.85M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$7.27M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$7.27M
13 of 13 sales
Net
+$27.58M
+$27.58M against sales at will

By person

16 insiders · 89 transactions
0.6×

Craig Parker holds only 0.6 times base salary in stock. $386.22K of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Craig Parker last reported holding, valued at $21.25, the price Common Stock was last bought or sold at on the open market here, on 22 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
COLUMN GROUP III GP, LP entity
10% owner
$20.98M (23)
+$20.98M
1,016,658
$21.60M
Kutzkey Tim
Director
$8.98M (20)
+$8.98M
1,016,658
$21.60M
+150.5%
TCG Crossover GP II, LLC entity
10% owner
$4.88M (20)
$6.91M (2)
−$2.03M
574,047
$12.20M
−18.0%
Parker Craig C
Chief Executive Officer
(1)
$150.80K (1)
−$150.80K
18,175
$386.22K
Williams Charles O
Chief Operating Officer
(1)
$119.49K (3)
−$119.49K
18,237
$387.54K
Li Yang
Exec. Vice President, Research
$89.65K (3)
−$89.65K
18,882
$401.24K
+122.1%
BLUTT MITCHELL J MD
10% owner
(5)
(4)
$0.00
6,750,500
$143.45M
−17.7%
Consonance Life Sciences
Former 10% Holder
(2)
$0.00
2,319,000
$49.28M
−12.3%
Livingston Kevin Harold
Former Chief Financial Officer
(2)
$0.00
1,885,000
$40.06M
−14.7%
Soffer Benny
FORMER DIRECTOR
(2)
$0.00
1,885,000
$40.06M
−14.7%
Vanhove Geertrui
Chief Medical Officer
32,412
$688.76K
+41.9%
Jarrett Jennifer
Former Director
30,000
$637.50K
Haqq Christopher
Former Director
30,000
$637.50K
Santel Donald J
Former Director
30,000
$637.50K
Yeh Wen-Chen
Chief Scientific Officer
27,216
$578.34K
Maleki Andrew Pedrum
Chief Financial Officer
607
$12.90K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 3,249,798 to 11,753,558 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
TCG Crossover GP II, LLC
22 Jul 2026
10% owner
Sell indirect
162,500
$21.25
$3.45M
TCG Crossover GP II, LLC
22 Jul 2026
10% owner
Sell indirect
162,500
$21.25
$3.45M
Parker Craig C
4 May 2026
Chief Executive Officer
Sell
4,524
$33.33
$150.80K
Williams Charles O
4 May 2026
Chief Operating Officer
Sell
2,036
$33.33
$67.87K
Li Yang
4 May 2026
Exec. Vice President, Research
Sell
1,584
$33.33
$52.80K
TCG Crossover GP II, LLC
24 Mar 2026
10% owner
Buy indirect
53,329
$24.69
$1.32M
TCG Crossover GP II, LLC
24 Mar 2026
10% owner
Buy indirect
53,329
$24.69
$1.32M
TCG Crossover GP II, LLC
23 Mar 2026
10% owner
Buy indirect
7,611
$24.90
$189.51K
TCG Crossover GP II, LLC
23 Mar 2026
10% owner
Buy indirect
7,612
$24.90
$189.54K
TCG Crossover GP II, LLC
16 Mar 2026
10% owner
Buy indirect
595
$24.99
$14.87K
TCG Crossover GP II, LLC
16 Mar 2026
10% owner
Buy indirect
595
$24.99
$14.87K
TCG Crossover GP II, LLC
13 Mar 2026
10% owner
Buy indirect
17,716
$24.88
$440.72K
TCG Crossover GP II, LLC
13 Mar 2026
10% owner
Buy indirect
17,717
$24.88
$440.74K
TCG Crossover GP II, LLC
12 Mar 2026
10% owner
Buy indirect
6,187
$24.99
$154.58K
TCG Crossover GP II, LLC
12 Mar 2026
10% owner
Buy indirect
6,187
$24.99
$154.58K
TCG Crossover GP II, LLC
12 Feb 2026
10% owner
Buy indirect
546
$23.86
$13.03K
TCG Crossover GP II, LLC
12 Feb 2026
10% owner
Buy indirect
547
$23.86
$13.05K
TCG Crossover GP II, LLC
11 Feb 2026
10% owner
Buy indirect
8,881
$23.58
$209.37K
TCG Crossover GP II, LLC
11 Feb 2026
10% owner
Buy indirect
8,882
$23.58
$209.39K
TCG Crossover GP II, LLC
3 Feb 2026
10% owner
Buy indirect
2,177
$21.94
$47.76K
TCG Crossover GP II, LLC
3 Feb 2026
10% owner
Buy indirect
2,178
$21.94
$47.79K
TCG Crossover GP II, LLC
2 Feb 2026
10% owner
Buy indirect
365
$21.38
$7.80K
TCG Crossover GP II, LLC
2 Feb 2026
10% owner
Buy indirect
366
$21.38
$7.83K
TCG Crossover GP II, LLC
30 Jan 2026
10% owner
Buy indirect
2,135
$21.39
$45.67K
TCG Crossover GP II, LLC
30 Jan 2026
10% owner
Buy indirect
2,136
$21.39
$45.69K
Kutzkey Tim
20 Jan 2026
Director
Buy indirect
9,568
$19.60
$187.53K
Kutzkey Tim
20 Jan 2026
Director
Buy indirect
8,484
$19.60
$166.29K
COLUMN GROUP III GP, LP
20 Jan 2026
10% owner
Buy indirect
9,568
$19.60
$187.53K
COLUMN GROUP III GP, LP
20 Jan 2026
10% owner
Buy indirect
8,484
$19.60
$166.29K
Kutzkey Tim
16 Jan 2026
Director
Buy indirect
1,358
$20.00
$27.16K
Kutzkey Tim
16 Jan 2026
Director
Buy indirect
1,204
$20.00
$24.08K
COLUMN GROUP III GP, LP
16 Jan 2026
10% owner
Buy indirect
1,358
$20.00
$27.16K
COLUMN GROUP III GP, LP
16 Jan 2026
10% owner
Buy indirect
1,204
$20.00
$24.08K
Kutzkey Tim
15 Jan 2026
Director
Buy indirect
6,303
$19.89
$125.36K
Kutzkey Tim
15 Jan 2026
Director
Buy indirect
5,590
$19.89
$111.18K
COLUMN GROUP III GP, LP
15 Jan 2026
10% owner
Buy indirect
6,303
$19.89
$125.36K
COLUMN GROUP III GP, LP
15 Jan 2026
10% owner
Buy indirect
5,590
$19.89
$111.18K
COLUMN GROUP III GP, LP
14 Jan 2026
10% owner
Buy indirect
2,927
$19.99
$58.51K
COLUMN GROUP III GP, LP
14 Jan 2026
10% owner
Buy indirect
2,596
$19.99
$51.89K
Kutzkey Tim
14 Jan 2026
Director
Buy indirect
2,927
$19.99
$58.51K
Kutzkey Tim
14 Jan 2026
Director
Buy indirect
2,596
$19.99
$51.89K
COLUMN GROUP III GP, LP
13 Jan 2026
10% owner
Buy indirect
6,609
$19.80
$130.89K
COLUMN GROUP III GP, LP
13 Jan 2026
10% owner
Buy indirect
5,861
$19.80
$116.07K
Kutzkey Tim
13 Jan 2026
Director
Buy indirect
6,609
$19.80
$130.89K
Kutzkey Tim
13 Jan 2026
Director
Buy indirect
5,861
$19.80
$116.07K
Kutzkey Tim
6 Jan 2026
Director
Buy indirect
8,003
$19.89
$159.16K
Kutzkey Tim
6 Jan 2026
Director
Buy indirect
7,097
$19.89
$141.14K
COLUMN GROUP III GP, LP
6 Jan 2026
10% owner
Buy indirect
8,003
$19.89
$159.16K
COLUMN GROUP III GP, LP
6 Jan 2026
10% owner
Buy indirect
7,097
$19.89
$141.14K
Williams Charles O
5 Jan 2026
Chief Operating Officer
Sell
1,566
$19.87
$31.11K
Li Yang
5 Jan 2026
Exec. Vice President, Research
Sell
1,118
$19.87
$22.21K
COLUMN GROUP III GP, LP
5 Dec 2025
10% owner
Buy indirect
16,381
$19.54
$320.10K
COLUMN GROUP III GP, LP
5 Dec 2025
10% owner
Buy indirect
14,503
$19.54
$283.40K
Kutzkey Tim
5 Dec 2025
Director
Buy indirect
16,381
$19.54
$320.10K
Kutzkey Tim
5 Dec 2025
Director
Buy indirect
14,503
$19.54
$283.40K
COLUMN GROUP III GP, LP
4 Dec 2025
10% owner
Buy indirect
2,791
$17.35
$48.42K
COLUMN GROUP III GP, LP
4 Dec 2025
10% owner
Buy indirect
2,475
$17.35
$42.93K
Kutzkey Tim
4 Dec 2025
Director
Buy indirect
2,791
$17.35
$48.42K
Kutzkey Tim
4 Dec 2025
Director
Buy indirect
2,475
$17.35
$42.93K
COLUMN GROUP III GP, LP
13 Nov 2025
10% owner
Buy indirect
167,307
$12.65
$2.12M
COLUMN GROUP III GP, LP
13 Nov 2025
10% owner
Buy indirect
148,150
$12.65
$1.87M
Kutzkey Tim
13 Nov 2025
Director
Buy indirect
167,307
$12.65
$2.12M
Kutzkey Tim
13 Nov 2025
Director
Buy indirect
148,150
$12.65
$1.87M
COLUMN GROUP III GP, LP
26 Mar 2025
10% owner
Buy indirect
344,827
$11.60
$4.00M
COLUMN GROUP III GP, LP
26 Mar 2025
10% owner
Buy indirect
365,769
$11.60
$4.24M
COLUMN GROUP III GP, LP
26 Mar 2025
10% owner
Buy indirect
323,886
$11.60
$3.76M
Williams Charles O
3 Jan 2025
CFO and COO
Sell
1,181
$17.37
$20.51K
Li Yang
3 Jan 2025
Exec. Vice President, Research
Sell
843
$17.37
$14.64K
COLUMN GROUP III GP, LP
4 Apr 2024
10% owner
Buy indirect
102,651
$15.50
$1.59M
COLUMN GROUP III GP, LP
4 Apr 2024
10% owner
Buy indirect
90,897
$15.50
$1.41M
Kutzkey Tim
4 Apr 2024
Director
Buy indirect
102,651
$15.50
$1.59M
Kutzkey Tim
4 Apr 2024
Director
Buy indirect
90,897
$15.50
$1.41M
Parker Craig C
4 Apr 2024
Chief Executive Officer
Buy
1,474
no price
Williams Charles O
4 Apr 2024
CFO and COO
Buy
1,474
no price
BLUTT MITCHELL J MD
14 Dec 2022
10% owner
Sell indirect
1,885,000
no price
BLUTT MITCHELL J MD
14 Dec 2022
10% owner
Sell indirect
450,827
no price
BLUTT MITCHELL J MD
14 Dec 2022
10% owner
Sell indirect
1,297,922
no price
BLUTT MITCHELL J MD
14 Dec 2022
10% owner
Sell indirect
1,748,750
no price
Livingston Kevin Harold
1 Dec 2020
Chief Financial Officer
Buy indirect
24,000
no price
Soffer Benny
1 Dec 2020
Director
Buy indirect
24,000
no price
Consonance Life Sciences
1 Dec 2020
10% owner
Buy
24,000
no price
BLUTT MITCHELL J MD
1 Dec 2020
Director
Buy indirect
24,000
no price
Soffer Benny
23 Nov 2020
Director
Buy indirect
410,000
no price
Consonance Life Sciences
23 Nov 2020
10% owner
Buy
410,000
no price
BLUTT MITCHELL J MD
23 Nov 2020
Director
Buy indirect
410,000
no price
Livingston Kevin Harold
23 Nov 2020
Chief Financial Officer
Buy indirect
410,000
no price
BLUTT MITCHELL J MD
23 Nov 2020
Director
Buy indirect
128,900
no price
BLUTT MITCHELL J MD
23 Nov 2020
Director
Buy indirect
371,100
no price
BLUTT MITCHELL J MD
23 Nov 2020
Director
Buy indirect
500,000
no price

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 17
Shares from compensation/vesting 18,335,678
Sales filed before the plan box existed 4
History held since 25 Nov 2020